Biolife launches WoundSeal first aid product targeting blood-thinner patients

SARASOTA, Fla. — Biolife last month launched WoundSeal, a hemostat product specifically targeting Americans on a regimen of blood thinners. The first aid powder instantly helps to stop bleeding, Biolife noted.

According to the company, as many as 52 million Americans are taking blood thinners and 11% stop taking those medicines because of "nuisance bleeding."

WoundSeal combines a hydrophilic polymer and potassium ferrate to create and instant scab when combined with blood. The instant scab seals the wound, which stops the bleeding, and helps prevent infection by creating a microbial barrier over and around the wound. The scab that's created remains in place until the wound is healed and it falls off naturally, Biolife said.

The company is working on a line extension for the product — WoundSeal for Nosebleeds — that includes a specially-designed applicator for nosebleeds or other hard-to-reach areas, such as head wounds.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

Login or Register to post a comment.